Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
Gerard J. Criner(Temple University Hospital), Stephen C. Lazarus(University of California, San Francisco), Frank C. Sciurba(Pulmonary and Allergy Associates), Don D. Sin(University of British Columbia), Mark T. Dransfield(University of Alabama at Birmingham), Jeffrey L. Curtis(VA Ann Arbor Healthcare System), Barry J. Make(National Jewish Health), Richard Casaburi(UCLA Medical Center), Shawn D. Aaron(Ottawa Hospital), Nathaniel Marchetti, George R. Washko(Brigham and Women's Hospital), Prescott G. Woodruff(University of California, San Francisco), Steven M. Scharf(University of Maryland, Baltimore), John A. Cooper(Washington University in St. Louis), John E. Connett(University of Utah), Fernando J. Martínez(University of Massachusetts Chan Medical School), Paul D. Scanlon(Mayo Clinic), Helen Voelker(University of Minnesota System), Dennis E. Niewoehner, Richard Albert(Goethe University Frankfurt), William C. Bailey(University of Alabama at Birmingham), MeiLan K. Han(University of Michigan)
Cited by 346
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k